PHAT
Phathom Pharmaceuticals Inc
7.30$
+3.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +74.6% | -13.9% | -10.4% | +21.2% | -2.3% | -22.2% | -15.0% | -4.0% | +7.8% | +17.7% | +7.2% | |
| – | +75.3% | -14.4% | -10.4% | +22.6% | -3.7% | -26.4% | -17.4% | -5.1% | +10.2% | +20.8% | +7.0% | |
| – | +78.5% | -15.5% | -14.3% | +21.2% | -11.2% | -28.6% | -29.6% | -9.6% | -3.8% | +39.2% | +0.9% | |
| – | +78.5% | -15.5% | -14.3% | +21.2% | -11.2% | -28.6% | -29.6% | -9.6% | -3.8% | +39.2% | +0.9% | |
| – | – | +137.0% | +180.4% | +93.5% | +84.3% | -6.3% | +40.9% | +8.8% | +40.0% | +3.3% | +20.7% | |
| – | +988.3% | +20.7% | +49.3% | +42.9% | +3.1% | -1.3% | +8.4% | +5.2% | +52.8% | +17.9% | +18.5% | |
| – | +91.0% | +3.8% | +9.5% | +3.8% | +10.1% | +0.1% | +3.7% | +1.0% | +5.2% | -7.9% | +4.6% | |
| – | +61.7% | +12.1% | +8.2% | +38.9% | +31.3% | -13.6% | +24.0% | +1.4% | +41.8% | -5.3% | +23.0% | |
| – | +0.7% | +0.6% | -1.4% | -5.6% | -26.3% | -36.9% | -24.7% | +148.3% | +9.6% | +2.9% | +0.4% | |
| – | +118.5% | -33.6% | -8.5% | -6.8% | +47.3% | +10.6% | -65.5% | -73.2% | +363.5% | +27.7% | -15.8% | |
| – | +38.9% | +8.1% | +17.0% | +0.7% | +14.6% | +0.9% | +0.9% | +1.0% | +1.0% | -21.7% | +0.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -9.7% | +13.8% | +0.3% | +10.4% | +9.9% | +1.3% | +0.7% | +1.3% | +0.6% | +11.2% | +2.1% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.